Am I audible now?
Thank you so much for taking my question. First question is on Saroglitazar. If I understand correctly, our data will be out by December or year-end. What is our strategy for the PBC indication post-trial?
Questions across 3 calls
Amey Chalke
Firm not listed in source transcripts
Zydus Lifesciences Limited
Aurobindo Pharma Limited
Thank you so much for giving me an opportunity to ask a question and congrats to the management on the good set of numbers. First question, is it possible for management to guide how the Revlimid sales have moved from quarter four to quarter one?
Sure. I don't want quantification, but qualitatively, is it possible to guide?
Thank you so much. Most of my questions are answered, just one thing on the branded specialty U.S. Business, if management can highlight plans here or any milestones in the near term for this business? And what growth should we assume?
Yes, the spectrum portfolio which we have acquired.